Copy Link Print Information

Sulfasalazine

(Synonyms: NSC 667219; Salicylazosulfapyridine)
84 Cited Publications
Avis client

Based on 84 publication(s) in Google Scholar

Sulfasalazine (NSC 667219) is an anti-rheumatic agent for the research of rheumatoid arthritis and ulcerative colitis. Sulfasalazine can suppress NF-κB activity. Sulfasalazine is a type 1 ferroptosis inducer.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.57%
  • CAS No.: 599-79-1
  • Formule: C18H14N4O5S
  • Masse moléculaire:398.39
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Sulfasalazine Chemical Structure
    Sulfasalazine Chemical Structure
  • Experimental Validation Results for Sulfasalazine
  • Experimental Validation Results for Sulfasalazine
  • Experimental Validation Results for Sulfasalazine
  • Experimental Validation Results for Sulfasalazine
  • Experimental Validation Results for Sulfasalazine
CAS No.: 599-79-1
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Sulfasalazine:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Sulfasalazine

More
Customer Validation & Images
2D/3D Cell Culture and DifferentiationIn Vivo Efficacy StudyHistological Imaging/StainingWB
  • 2D/3D Cell Culture and Differentiation
  • In Vivo Efficacy Study
  • Histological Imaging/Staining
  • WB
  • WB

Voir tous les produits spécifiques à Isoform NF-κB

More

Voir tous les produits spécifiques à Isoform Antibiotic

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Sulfasalazine Chemical Structure
    Sulfasalazine Chemical Structure
    1/16
  • 1/16

    Sulfasalazine purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2025 Dec 25.

    Customer Validation
     Sulfasalazine (SSA, 0.1–100 mM, 24 h) inhibited cell growth in parental HCCLM3 cells and the indicated clones with reconstituted expression of the WTAP S176A (left) or knock-in expression of GLS Mut (right).

  • 1/16

    Sulfasalazine purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2025 Dec 25.

    Customer Validation
     Sulfasalazine (SAS, 100 mg/kg, i.p., 30 days) inhibited tumor growth in athymic nude mice bearing HCCLM3 cells with wildtype or WTAP S176A mutant.

  • 1/16

    Sulfasalazine purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2025 Dec 25.

    Customer Validation
     Sulfasalazine (SAS, 100 mg/kg, i.p., 30 days) decreased GAC expression and increased 4-HE expression in athymic nude mice bearing either wildtype HCCLM3 cells or cells expressing the WTAP S176A mutant.

  • 1/16

    Sulfasalazine purchased from MedChemExpress. Usage Cited in: Mol Ther. 2021 Jul 7;29(7):2321-2334. [Abstract]

    Customer Validation
     PD-L1 expression is significantly increased after Sulfasalazine (SAS) treatment at both the protein and mRNA levels.

  • 1/16

    Sulfasalazine purchased from MedChemExpress. Usage Cited in: Cell Res. 2018 Dec;28(12):1171-1185. [Abstract]

    Customer Validation
     Melanoma A375 cells are treated with SSZ (Sulfasalazine, 125 μM) with or without FeSO4 (100 μM) for 6 h to detect the ROS level or 24 h to assess the pyroptotic features (including morphology, GSDME cleavage, and LDH release), unless specifically defined.

  • Sulfasalazine